3Suppliers
2Customers
1Debt Items
0Related Chains

AtriCure, Inc. Suppliers

TickerNameConfidenceEvidence
CLINICAL-TRIAL-SITES CLINICAL-TRIAL-SITES 90% The Company incurs additional variable costs, including pass through costs from clinical trial sites.
CLOUD-COMPUTING-PROVIDER CLOUD-COMPUTING-PROVIDER 90% In 2025, the Company entered into a non-cancellable cloud computing arrangement with a term of seven years requiring total payments of $ 3,616.
THIRD-PARTY-SUPPLIERS THIRD-PARTY-SUPPLIERS 90% The Company is dependent on third-party suppliers, in some cases single-source suppliers.

AtriCure, Inc. Customers

TickerNameConfidenceEvidence
ATRICURE-EUROPE-B-V ATRICURE-EUROPE-B-V 90% Products sold by AtriCure Europe, B.V. and its subsidiaries are denominated in Euros or British Pounds.
TOP-TEN-CUSTOMERS TOP-TEN-CUSTOMERS 85% During 2025, 2024 and 2023, 8.7 %, 8.9 % and 8.8 % of the Company's total revenue was derived from its top ten customers.

AtriCure, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ATRC-DEBT Debt stack $74.9M 90% Market cache reports total debt of $74.9M.

AtriCure, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for AtriCure, Inc..

AtriCure, Inc. Ownership

HolderNameConfidenceEvidence
ATRC-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 227 tracked holders.

AtriCure, Inc. Extended Supply Chain Network

No secondary connectionsNo correlated companies found through shared supply chain relationships.